Teratogenicity of therapeutic agents.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000016:Abnormalities, Radiation-Induced / Q000209:etiology; D000028:Abortion, Induced / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D000013:Congenital Abnormalities / Q000209:etiology*; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005260:Female; D006728:Hormones / Q000009:adverse effects; D006801:Humans; D008297:Male; D008767:Methylmercury Compounds / Q000633:toxicity; D010672:Phenytoin / Q000009:adverse effects; D011247:Pregnancy; D013723:Teratogens; D013752:Tetracycline / Q000009:adverse effects; D013792:Thalidomide / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects; D014293:Trimethadione / Q000009:adverse effects
D000777:Anesthetics; D000925:Anticoagulants; D000970:Antineoplastic Agents; D006728:Hormones; D008767:Methylmercury Compounds; D013723:Teratogens; D014149:Tranquilizing Agents; D013792:Thalidomide; D010672:Phenytoin; D013752:Tetracycline; D001241:Aspirin; D014293:Trimethadione